Clinical trial
A Phase I Study of GNX102 in Patients With Advanced Solid Tumors
NCT04250597 is registered in ClinicalTrials.gov with GlycoNex, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of GNX102 in Patients With Advanced Solid Tumors
- Lead sponsor
- GlycoNex, Inc.
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- July 29, 2020
- Completion date
- July 26, 2023
- Enrollment
- 46 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer, metastatic cancer, solid tumor, unresectable solid neoplasm